Dr. Mark Warren Clemens II, MD

Dr. Clemens practices at The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System.

Dr. Clemens' NPI, 1730340852, was assigned on June 20, 2008. Dr. Clemens graduated from Penn State College of Medicine in 2004. Dr. Clemens holds Texas license N6226.

Dr. Clemens' primary practice is The University of Texas MD Anderson Cancer Center, at 1515 Holcombe Blvd, Houston, TX 77030.

Dr. Clemens' primary practice is The University of Texas MD Anderson Cancer Center in Houston, Texas, part of The University of Texas System. The medical group on file is Physicians Referral Service.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Clemens practices. Vendor and product names are available with a free account.

Plastic surgery is Dr. Clemens' primary specialty in the NPI Registry, under taxonomy code 208200000X. Dr. Clemens is board certified in plastic surgery by the American Board of Plastic Surgery. Dmand AI has Dr. Clemens' licenses on file in 12 states: Texas, Florida, Arizona, Oklahoma, Washington, Alabama, Georgia, Louisiana, Mississippi, Tennessee, District of Columbia and Virginia.

Dmand AI lists breast reconstruction and breast surgery among the conditions Dr. Clemens treats.

CMS data shows 24 Medicare services from Dr. Clemens across 1 procedure code in 2024, all of them office visits, for 33 Medicare patients. Medicare paid $2,555 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 33 Medicare patients who saw Dr. Clemens in 2024. 75% of them have cancer, and 73% have high cholesterol. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Clemens' median patient age at 62, with 98% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Clemens for performance year 2024, reported as part of a group. Dr. Clemens accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of mastectomy by Dr. Clemens, more than 87% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 162 papers to Dr. Clemens, published from 2008 to 2025. 2022 was the busiest year, with 12. The most frequent topics are Breast Implants, Breast Neoplasms and Lymphoma, Large-Cell, Anaplastic. Dr. Clemens has published most often in Plast Reconstr Surg. Dr. Clemens' most frequent co-authors are Charles E. Butler, MD, Roberto N. Miranda, MD and Jesse C. Selber, MD.

Dmand AI links Dr. Clemens to 1 clinical trial. Conditions studied include Breast Neoplasms and Breast Diseases.

CMS Open Payments shows 160 general payments to Dr. Clemens from 23 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 46% of the total. Allergan Inc. paid the most, $69,691.

Dr. Clemens graduated from Penn State College of Medicine in 2004.

Dr. Clemens is in network with 4 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 3. Check the plan with the practice before a visit.